Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene citrate for anabolic steroid-induced hypogonadism after AAS cessation
2020-005938-15Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of clomiphene in Hypogonadism (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Safety and symptom reduction during 16 weeks of clomiphene citrate. Started Aug 2021; status: completed.
02
Drugs
clomiphene
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on 2020-005938-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005938-15.